Literature DB >> 27347605

Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.

Eisuke Miyauchi1, Masanori Tachikawa1, Xavier Declèves2,3, Yasuo Uchida1, Jean-Luc Bouillot4, Christine Poitou5, Jean-Michel Oppert5, Stéphane Mouly2,6, Jean-François Bergmann2,6, Tetsuya Terasaki1, Jean-Michel Scherrmann2, Célia Lloret-Linares2,6.   

Abstract

Protein expression levels of drug-metabolizing enzymes and transporters in human jejunal tissues excised from morbidly obese subjects during gastric bypass surgery were evaluated using quantitative targeted absolute proteomics. Protein expression levels of 15 cytochrome P450 (CYP) enzymes, 10 UDP-glucuronosyltransferase (UGT) enzymes, and NADPH-P450 reductase (P450R) in microsomal fractions from 28 subjects and 49 transporters in plasma membrane fractions from 24 of the same subjects were determined using liquid chromatography-tandem mass spectrometry. Based on average values, UGT1A1, UGT2B15, UGT2B17, SGLT1, and GLUT2 exhibited high expression levels (over 10 fmol/μg protein), though UGT2B15 expression was detected at a high level in only one subject. CYP2C9, CYP2D6, CYP3A5, UGT1A6, P450R, ABCG2, GLUT5, PEPT1, MCT1, 4F2 cell-surface antigen heavy chain (4F2hc), LAT2, OSTα, and OSTβ showed intermediate levels (1-10 fmol/μg protein), and CYP1A1, CYP1A2, CYP1B1, CYP2C18, CYP2C19, CYP2J2, CYP3A7, CYP4A11, CYP51A1, UGT1A3, UGT1A4, UGT1A8, UGT2B4, ABCC1, ABCC4, ABCC5, ABCC6, ABCG8, TAUT, OATP2A1, OATP2B1, OATP3A1, OATP4A1, OCTN1, CNT2, PCFT, MCT4, GLUT4, and SLC22A18 showed low levels (less than 1 fmol/μg protein). The greatest interindividual difference (364-fold) was detected for UGT2B17. However, differences in expression levels of other quantified UGTs (except UGT2B15 and UGT2B17), CYPs (except CYP1A1 and CYP3A5), and P450R, and all quantified transporters, were within 10-fold. Expression levels of CYP1A2 and GLUT4 were significantly correlated with body-mass index. The levels of 4F2hc showed significant gender differences. Smokers showed increased levels of UGT1A1 and UGT1A3. These findings provide a basis for understanding the changes in molecular mechanisms of jejunal metabolism and transport, as well as their interindividual variability, in morbidly obese patients.

Entities:  

Keywords:  BCRP/ABCG2; CYP; OATP2B1; UGT2B17; drug-metabolizing enzymes; morbid obesity; small intestine; transporter

Mesh:

Substances:

Year:  2016        PMID: 27347605     DOI: 10.1021/acs.molpharmaceut.6b00085

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  21 in total

1.  Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.

Authors:  Taleah Farasyn; Alexandra Crowe; Oliver Hatley; Sibylle Neuhoff; Khondoker Alam; Jean Kanyo; TuKiet T Lam; Kai Ding; Wei Yue
Journal:  J Pharm Sci       Date:  2019-04-30       Impact factor: 3.534

Review 2.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

3.  Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2α Inhibitor PT2385 In Vivo and In Vitro.

Authors:  Cen Xie; Xiaoxia Gao; Dongxue Sun; Youbo Zhang; Kristopher W Krausz; Xuemei Qin; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2018-01-23       Impact factor: 3.922

4.  Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.

Authors:  Valérie Clermont; Alexia Grangeon; Azemi Barama; Jacques Turgeon; Michel Lallier; Jacques Malaise; Veronique Michaud
Journal:  Br J Clin Pharmacol       Date:  2019-04-13       Impact factor: 4.335

Review 5.  Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics.

Authors:  Deepak Kumar Bhatt; Bhagwat Prasad
Journal:  Clin Pharmacol Ther       Date:  2017-09-25       Impact factor: 6.875

6.  One-anastomosis gastric bypass modulates the serum levels of pro- and anti-inflammatory oxylipins, which may contribute to the resolution of inflammation.

Authors:  Ivan Liakh; Agata Janczy; Alicja Pakiet; Justyna Korczynska; Monika Proczko-Stepaniak; Lukasz Kaska; Tomasz Sledzinski; Adriana Mika
Journal:  Int J Obes (Lond)       Date:  2021-11-03       Impact factor: 5.095

7.  Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Yijun Pan; Kotaro Omori; Izna Ali; Masanori Tachikawa; Tetsuya Terasaki; Kim L R Brouwer; Joseph A Nicolazzo
Journal:  Mol Pharm       Date:  2018-08-22       Impact factor: 4.939

8.  Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.

Authors:  Haeyoung Zhang; Abdul Basit; Diana Busch; King Yabut; Deepak Kumar Bhatt; Marek Drozdzik; Marek Ostrowski; Albert Li; Carol Collins; Stefan Oswald; Bhagwat Prasad
Journal:  Biochem Pharmacol       Date:  2018-08-04       Impact factor: 5.858

9.  Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.

Authors:  Eisuke Miyauchi; Takuya Furuta; Sumio Ohtsuki; Masanori Tachikawa; Yasuo Uchida; Hemragul Sabit; Wataru Obuchi; Tomoko Baba; Michitoshi Watanabe; Tetsuya Terasaki; Mitsutoshi Nakada
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

Review 10.  Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters.

Authors:  Jiapeng Li; Hao-Jie Zhu
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.